LEADER 02287nam  22005533u 450 
001 9910465455503321
005 20210114104908.0
010   $a1-78084-309-7
035   $a(CKB)2560000000152104
035   $a(EBL)1179627
035   $a(SSID)ssj0001599919
035   $a(PQKBManifestationID)16306842
035   $a(PQKBTitleCode)TC0001599919
035   $a(PQKBWorkID)14892848
035   $a(PQKB)11518884
035   $a(MiAaPQ)EBC1179627
035   $a(Au-PeEL)EBL1179627
035   $a(OCoLC)876507114
035   $a(EXLCZ)992560000000152104
100   $a20140414d2013||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAdvances in the Management of Pulmonary Arterial Hypertension$b[electronic resource]
205   $a1st ed.
210   $aLondon $cFuture Medicine Ltd$d2013
215   $a1 online resource (129 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-311-9 
327   $aTitle page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension
327   $a9. Right ventricular failureIndex
330   $aAdvances in the Management of Pulmonary Arterial Hypertension
606   $aPulmonary hypertension -- Treatment
606   $aPulmonary hypertension
608   $aElectronic books.
615  4$aPulmonary hypertension -- Treatment.
615  4$aPulmonary hypertension.
676   $a616.1/32 
700   $aYuan$b Jason X-J$01048660
701   $aSmith$b Kimberly A$01048661
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910465455503321
996   $aAdvances in the Management of Pulmonary Arterial Hypertension$92477084
997   $aUNINA